BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11313904)

  • 1. Protease activated receptors: theme and variations.
    O'Brien PJ; Molino M; Kahn M; Brass LF
    Oncogene; 2001 Mar; 20(13):1570-81. PubMed ID: 11313904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease-activated receptors: a means of converting extracellular proteolysis into intracellular signals.
    Mackie EJ; Pagel CN; Smith R; de Niese MR; Song SJ; Pike RN
    IUBMB Life; 2002 Jun; 53(6):277-81. PubMed ID: 12625364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated G protein-coupled receptors on human platelets and endothelial cells.
    Brass LF; Molino M
    Thromb Haemost; 1997 Jul; 78(1):234-41. PubMed ID: 9198159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
    Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
    Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
    Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
    Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells.
    Greenberg DL; Mize GJ; Takayama TK
    Biochemistry; 2003 Jan; 42(3):702-9. PubMed ID: 12534282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinase-activated receptors.
    Macfarlane SR; Seatter MJ; Kanke T; Hunter GD; Plevin R
    Pharmacol Rev; 2001 Jun; 53(2):245-82. PubMed ID: 11356985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease activated receptors in cardiovascular function and disease.
    Barnes JA; Singh S; Gomes AV
    Mol Cell Biochem; 2004 Aug; 263(1-2):227-39. PubMed ID: 15524183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiovascular actions of protease-activated receptors.
    Steinberg SF
    Mol Pharmacol; 2005 Jan; 67(1):2-11. PubMed ID: 15371558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective tryptic cleavage at the tethered ligand site of the amino terminal domain of proteinase-activated receptor-2 in intact cells.
    Al-Ani B; Hollenberg MD
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1120-8. PubMed ID: 12604689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAR3 is a cofactor for PAR4 activation by thrombin.
    Nakanishi-Matsui M; Zheng YW; Sulciner DJ; Weiss EJ; Ludeman MJ; Coughlin SR
    Nature; 2000 Apr; 404(6778):609-13. PubMed ID: 10766244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling through G proteins and G protein-coupled receptors during platelet activation.
    Brass LF; Hoxie JA; Manning DR
    Thromb Haemost; 1993 Jul; 70(1):217-23. PubMed ID: 8236108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
    Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
    Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrapancreatic trypsin-2 cleaves proteinase-activated receptor-2.
    Alm AK; Gagnemo-Persson R; Sorsa T; Sundelin J
    Biochem Biophys Res Commun; 2000 Aug; 275(1):77-83. PubMed ID: 10944445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-activated receptor 3 is a second thrombin receptor in humans.
    Ishihara H; Connolly AJ; Zeng D; Kahn ML; Zheng YW; Timmons C; Tram T; Coughlin SR
    Nature; 1997 Apr; 386(6624):502-6. PubMed ID: 9087410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
    Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
    J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase-activated receptors: a growing family of heptahelical receptors for thrombin, trypsin and tryptase.
    Déry O; Bunnett NW
    Biochem Soc Trans; 1999 Feb; 27(2):246-54. PubMed ID: 10093742
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombin receptors: turning them off after turning them on.
    Brass LF; Ahuja M; Belmonte E; Blanchard N; Pizarro S; Tarver A; Hoxie JA
    Semin Hematol; 1994 Jul; 31(3):251-60. PubMed ID: 7973781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated receptors: new concepts in regulation of G protein-coupled receptor signaling and trafficking.
    Trejo J
    J Pharmacol Exp Ther; 2003 Nov; 307(2):437-42. PubMed ID: 12966163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin signaling in the brain: the role of protease-activated receptors.
    Wang H; Reiser G
    Biol Chem; 2003 Feb; 384(2):193-202. PubMed ID: 12675511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.